{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:28:22Z","timestamp":1793780902712,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA87969"],"award-info":[{"award-number":["P01 CA87969"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA49449"],"award-info":[{"award-number":["R01 CA49449"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["UM1 CA176726"],"award-info":[{"award-number":["UM1 CA176726"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA67262"],"award-info":[{"award-number":["R01 CA67262"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1038\/s41416-019-0422-9","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:04:09Z","timestamp":1553126649000},"page":"855-860","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses\u2019 Health Studies"],"prefix":"10.1038","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1426-8505","authenticated-orcid":false,"given":"Ren\u00e9e T.","family":"Fortner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Hufnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Waterboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley S.","family":"Tworoger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"422_CR1","doi-asserted-by":"publisher","first-page":"959816","DOI":"10.1155\/2011\/959816","volume":"2011","author":"CL Haggerty","year":"2011","unstructured":"Haggerty, C. L. & Taylor, B. D. Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease. Infect. Dis. Obstet. Gynecol. 2011, 959816 (2011).","journal-title":"Infect. Dis. Obstet. Gynecol."},{"issue":"suppl_2","key":"422_CR2","doi-asserted-by":"publisher","first-page":"S389","DOI":"10.1093\/infdis\/jix198","volume":"216","author":"HC Wiesenfeld","year":"2017","unstructured":"Wiesenfeld, H. C. & Manhart, L. E. Mycoplasma genitalium in women: current knowledge and research priorities for this recently emerged pathogen. J. Infect. Dis. 216(suppl_2), S389\u2013S395 (2017).","journal-title":"J. Infect. Dis."},{"key":"422_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1258\/095646205774763270","volume":"16","author":"S Barrett","year":"2005","unstructured":"Barrett, S. & Taylor, C. A review on pelvic inflammatory disease. Int. J. STD AIDS 16, 715\u2013720 (2005).","journal-title":"Int. J. STD AIDS"},{"key":"422_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10552-017-0873-3","volume":"28","author":"Z Zhou","year":"2017","unstructured":"Zhou, Z., Zeng, F., Yuan, J., Tang, J., Colditz, G. A. & Tworoger, S. S. et al. Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis. Cancer Causes Control 28, 415\u2013428 (2017).","journal-title":"Cancer Causes Control"},{"issue":"Suppl 10","key":"422_CR5","doi-asserted-by":"publisher","first-page":"x16","DOI":"10.1093\/annonc\/mdt463","volume":"24","author":"RJ Kurman","year":"2013","unstructured":"Kurman, R. J. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. Ann. Oncol. 24(Suppl 10), x16\u2013x21 (2013).","journal-title":"Ann. Oncol."},{"key":"422_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00962-1","volume":"8","author":"SI Labidi-Galy","year":"2017","unstructured":"Labidi-Galy, S. I., Papp, E., Hallberg, D., Niknafs, N., Adleff, V. & Noe, M. et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat. Commun. 8, 1093 (2017).","journal-title":"Nat. Commun."},{"key":"422_CR7","first-page":"296","volume":"10","author":"AA Tone","year":"2012","unstructured":"Tone, A. A., Salvador, S., Finlayson, S. J., Tinker, A. V., Kwon, J. S. & Lee, C. H. et al. The role of the fallopian tube in ovarian cancer. Clin. Adv. Hematol. Oncol. 10, 296\u2013306 (2012).","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"422_CR8","doi-asserted-by":"publisher","first-page":"824627","DOI":"10.1155\/2011\/824627","volume":"2011","author":"A Idahl","year":"2011","unstructured":"Idahl, A., Lundin, E., Jurstrand, M., Kumlin, U., Elgh, F. & Ohlson, N. et al. Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors. Infect. Dis. Obstet. Gynecol. 2011, 824627 (2011).","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"422_CR9","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1086\/368380","volume":"187","author":"RB Ness","year":"2003","unstructured":"Ness, R. B., Goodman, M. T., Shen, C. & Brunham, R. C. Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer. J. Infect. Dis. 187, 1147\u20131152 (2003).","journal-title":"J. Infect. Dis."},{"key":"422_CR10","doi-asserted-by":"publisher","first-page":"219672","DOI":"10.1155\/2008\/219672","volume":"2008","author":"RB Ness","year":"2008","unstructured":"Ness, R. B., Shen, C., Bass, D., Jackson, C., Moysich, K. & Edwards, R. et al. Chlamydia trachomatis serology in women with and without ovarian cancer. Infect. Dis. Obstet. Gynecol. 2008, 219672 (2008).","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"422_CR11","first-page":"117","volume":"28","author":"A Wong","year":"2007","unstructured":"Wong, A., Maclean, A. B., Furrows, S. J., Ridgway, G. L., Hardiman, P. J. & Perrett, C. W. Could epithelial ovarian cancer be associated with chlamydial infection? Eur. J. Gynaecol. Oncol. 28, 117\u2013120 (2007).","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"422_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/jnci\/djy084","volume":"111","author":"B Trabert","year":"2018","unstructured":"Trabert, B., Waterboer, T., Idahl, A., Brenner, N., Brinton, L. A. & Butt, J. et al. Antibodies against Chlamydia trachomatis and ovarian cancer risk in two independent populations. J. Natl. Cancer Inst. 111, 129\u2013136 (2018).","journal-title":"J. Natl. Cancer Inst."},{"key":"422_CR13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C de Martel","year":"2017","unstructured":"de Martel, C., Plummer, M., Vignat, J. & Franceschi, S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J. Cancer 141, 664\u2013670 (2017).","journal-title":"Int J. Cancer"},{"key":"422_CR14","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2016. Atlanta: U.S. Department of Health and Human Services, 2017."},{"key":"422_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrc1608","volume":"5","author":"GA Colditz","year":"2005","unstructured":"Colditz, G. A. & Hankinson, S. E. The Nurses\u2019 Health Study: lifestyle and health among women. Nat. Rev. Cancer 5, 388\u2013396 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"422_CR16","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/jnci\/djj376","volume":"98","author":"AH Eliassen","year":"2006","unstructured":"Eliassen, A. H., Missmer, S. A., Tworoger, S. S., Spiegelman, D., Barbieri, R. L. & Dowsett, M. et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J. Natl. Cancer Inst. 98, 1406\u20131415 (2006).","journal-title":"J. Natl. Cancer Inst."},{"key":"422_CR17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s10549-012-2391-z","volume":"137","author":"X Zhang","year":"2013","unstructured":"Zhang, X., Tworoger, S. S., Eliassen, A. H. & Hankinson, S. E. Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res. Treat. 137, 883\u2013892 (2013).","journal-title":"Breast Cancer Res. Treat."},{"key":"422_CR18","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/jnci\/90.17.1292","volume":"90","author":"SE Hankinson","year":"1998","unstructured":"Hankinson, S. E., Willett, W. C., Manson, J. E., Colditz, G. A., Hunter, D. J. & Spiegelman, D. et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst. 90, 1292\u20131299 (1998).","journal-title":"J. Natl. Cancer Inst."},{"key":"422_CR19","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3945\/jn.115.229666","volume":"146","author":"T Huang","year":"2016","unstructured":"Huang, T., Tobias, D. K., Hruby, A., Rifai, N., Tworoger, S. S. & Hu, F. B. An increase in dietary quality is associated with favorable plasma biomarkers of the brain-adipose axis in apparently healthy US women. J. Nutr. 146, 1101\u20131108 (2016).","journal-title":"J. Nutr."},{"key":"422_CR20","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1373\/clinchem.2005.052381","volume":"51","author":"T Waterboer","year":"2005","unstructured":"Waterboer, T., Sehr, P., Michael, K. M., Franceschi, S., Nieland, J. D. & Joos, T. O. et al. Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin. Chem. 51, 1845\u20131853 (2005).","journal-title":"Clin. Chem."},{"key":"422_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/aje\/kwv281","volume":"183","author":"M Karachaliou","year":"2016","unstructured":"Karachaliou, M., Waterboer, T., Casabonne, D., Chalkiadaki, G., Roumeliotaki, T. & Michel, A. et al. The natural history of human polyomaviruses and herpesviruses in early life--the Rhea Birth Cohort in Greece. Am. J. Epidemiol. 183, 671\u2013679 (2016).","journal-title":"Am. J. Epidemiol."},{"key":"422_CR22","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1200\/JCO.2012.47.2738","volume":"31","author":"AR Kreimer","year":"2013","unstructured":"Kreimer, A. R., Johansson, M., Waterboer, T., Kaaks, R., Chang-Claude, J. & Drogen, D. et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J. Clin. Oncol. 31, 2708\u20132715 (2013).","journal-title":"J. Clin. Oncol."},{"key":"422_CR23","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1002\/ijc.28888","volume":"135","author":"JD Combes","year":"2014","unstructured":"Combes, J. D., Pawlita, M., Waterboer, T., Hammouda, D., Rajkumar, T. & Vanhems, P. et al. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer. Int. J. Cancer 135, 2453\u20132461 (2014).","journal-title":"Int. J. Cancer"},{"key":"422_CR24","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/sim.6793","volume":"35","author":"M Wang","year":"2016","unstructured":"Wang, M., Spiegelman, D., Kuchiba, A., Lochhead, P., Kim, S. & Chan, A. T. et al. Statistical methods for studying disease subtype heterogeneity. Stat. Med. 35, 782\u2013800 (2016).","journal-title":"Stat. Med."},{"key":"422_CR25","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.chom.2013.05.010","volume":"13","author":"C Chumduri","year":"2013","unstructured":"Chumduri, C., Gurumurthy, R. K., Zadora, P. K., Mi, Y. & Meyer, T. F. Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response. Cell Host 13, 746\u2013758 (2013).","journal-title":"Cell Host"},{"key":"422_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1574-695X.2008.00515.x","volume":"55","author":"M Sharma","year":"2009","unstructured":"Sharma, M. & Rudel, T. Apoptosis resistance in Chlamydia-infected cells: a fate worse than death? FEMS Immunol. Med. Microbiol. 55, 154\u2013161 (2009).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"422_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.contraception.2015.01.004","volume":"92","author":"LM Hafner","year":"2015","unstructured":"Hafner, L. M. Pathogenesis of fallopian tube damage caused by Chlamydia trachomatis infections. Contraception 92, 108\u2013115 (2015).","journal-title":"Contraception"},{"key":"422_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1586\/14787210.4.2.235","volume":"4","author":"CL Haggerty","year":"2006","unstructured":"Haggerty, C. L. & Ness, R. B. Epidemiology, pathogenesis and treatment of pelvic inflammatory disease. Expert Rev. Antiinfect. Ther. 4, 235\u2013247 (2006).","journal-title":"Expert Rev. Antiinfect. Ther."},{"key":"422_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jog.12550","volume":"41","author":"F Zeppernick","year":"2015","unstructured":"Zeppernick, F., Meinhold-Heerlein, I. & Shih Ie, M. Precursors of ovarian cancer in the fallopian tube: serous tubal intraepithelial carcinoma--an update. J. Obstet. Gynaecol. Res. 41, 6\u201311 (2015).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"422_CR30","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1158\/1055-9965.EPI-14-1279-T","volume":"24","author":"J Ose","year":"2015","unstructured":"Ose, J., Schock, H., Tj\u00f8nneland, A., Hansen, L., Overvad, K. & Dossus, L. et al. Inflammatory markers and risk of epithelial ovarian cancer by tumor subtypes: the EPIC cohort. Cancer Epidemiol. Biomark. Prev. 24, 951\u2013961 (2015).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"422_CR31","doi-asserted-by":"publisher","first-page":"djt431","DOI":"10.1093\/jnci\/djt431","volume":"106","author":"B Trabert","year":"2014","unstructured":"Trabert, B., Ness, R. B., Lo-Ciganic, W. H., Murphy, M. A., Goode, E. L. & Poole, E. M. et al. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J. Natl. Cancer Inst. 106, djt431\u2013djt431 (2014).","journal-title":"J. Natl. Cancer Inst."},{"key":"422_CR32","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/aje\/kws583","volume":"178","author":"MJ Price","year":"2013","unstructured":"Price, M. J., Ades, A. E., De Angelis, D., Welton, N. J., Macleod, J. & Soldan, K. et al. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am. J. Epidemiol. 178, 484\u2013492 (2013).","journal-title":"Am. J. Epidemiol."},{"key":"422_CR33","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1093\/humrep\/deg347","volume":"18","author":"VA Akande","year":"2003","unstructured":"Akande, V. A., Hunt, L. P., Cahill, D. J., Caul, E. O., Ford, W. C. & Jenkins, J. M. Tubal damage in infertile women: prediction using chlamydia serology. Hum. Reprod. 18, 1841\u20131847 (2003).","journal-title":"Hum. Reprod."},{"key":"422_CR34","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/humrep\/del455","volume":"22","author":"A Baczynska","year":"2007","unstructured":"Baczynska, A., Funch, P., Fedder, J., Knudsen, H. J., Birkelund, S. & Christiansen, G. Morphology of human fallopian tubes after infection with Mycoplasma genitalium and Mycoplasma hominis--in vitro organ culture study. Hum. Reprod. 22, 968\u2013979 (2007).","journal-title":"Hum. Reprod."},{"key":"422_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/01.olq.0000218869.52753.c7","volume":"33","author":"TL Cherpes","year":"2006","unstructured":"Cherpes, T. L., Wiesenfeld, H. C., Melan, M. A., Kant, J. A., Cosentino, L. A. & Meyn, L. A. et al. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex. Transm. Dis. 33, 747\u2013752 (2006).","journal-title":"Sex. Transm. Dis."},{"key":"422_CR36","doi-asserted-by":"publisher","first-page":"e114750","DOI":"10.1371\/journal.pone.0114750","volume":"9","author":"D Pandya","year":"2014","unstructured":"Pandya, D., Mariani, M., McHugh, M., Andreoli, M., Sieber, S. & He, S. et al. Herpes virus microRNA expression and significance in serous ovarian cancer. PLoS ONE 9, e114750 (2014).","journal-title":"PLoS ONE"},{"key":"422_CR37","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen, H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2, 342\u2013350 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"422_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1023\/A:1011236803257","volume":"12","author":"M Hisada","year":"2001","unstructured":"Hisada, M., van den Berg, B. J., Strickler, H. D., Christianson, R. E., Wright, W. E. & Waters, D. J. et al. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States). Cancer Causes Control 12, 335\u2013341 (2001).","journal-title":"Cancer Causes Control"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0422-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0422-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0422-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:04:31Z","timestamp":1684616671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-019-0422-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["422"],"URL":"https:\/\/doi.org\/10.1038\/s41416-019-0422-9","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]},"assertion":[{"value":"5 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of the Brigham and Women\u2019s Hospital (Boston, MA). All participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Information on gaining access to NHS\/NHSII resources is available at: . Permission to access the data was granted by the Nurses\u2019 Health Study leadership.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Note"}}]}}